ARCHIVES

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

Hospitals Win Grants For Radiation Oncology Disparity Research.

January 3, 2003

New ACS Structure Proposed, approved

August 6, 1993

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992